Neng‐Yang Shih

Statistics

Publications

Citations

2.1K

H-Index

Active since

1984

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

LabCorp (United States)

AIL Research (United States)

Duke University

Neng‐Yang Shih is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

1984–2018

Publications

Identification of two H3-histamine receptor subtypes.

Randolph West, Adam Zweig, Neng‐Yang Shih et al. · Molecular Pharmacology · 1990 · 151 citations

Medicine, Medicinal Chemistry, Pharmacology +16

Discovery of Narlaprevir (SCH 900518): A Potent, Second Generation HCV NS3 Serine Protease Inhibitor

Ashok Arasappan, Frank Bennett, Stéphane Bogen et al. · ACS Medicinal Chemistry Letters · 2010 · 98 citations

Pharmacy, Medicinal Chemistry, Pharmacology +15

Characterization and tissue distribution of H3 histamine receptors in guinea pigs by Nα-methylhistamine

Alexandra Korte, Joyce Myers, Neng‐Yang Shih et al. · Biochemical and Biophysical Research Communications · 1990 · 93 citations

Medicine, Pharmacology, Hypersensitivity +4

Asymmetric Synthesis of 4,4-Disubstituted-2-Imidazoli-dinones: Potent NK<sub>1</sub> Antagonists

Gregory A. Reichard, Carmine N. Stengone, Sunil Paliwal et al. · Organic Letters · 2003 · 71 citations

Pharmacy, Medicinal Chemistry, Pharmacology +11

Preferential formation of 8-epi-prostaglandin f2α via the corresponding endoperoxide by a biomimetic cyclization

E. J. Corey, Chuan Shih, Neng‐Yang Shih et al. · Tetrahedron Letters · 1984 · 69 citations

Life Sciences, Biochemistry, Pharmacology +6

1–5 of 70